Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies …
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-photo-3683101.webp?resize=600%2C400&ssl=1)
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-photo-3683101.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies …